ScholarIQanswers from OpenAlex & ORCID
Renier J. Brentjens
ResearcherPublications, citations & collaboration network
Renier J. Brentjens is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Renier J. Brentjens have?
ScholarIQindexed works
Renier J. Brentjens has 416 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Renier J. Brentjens have?
ScholarIQcitation count
Renier J. Brentjens has 35,907 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Renier J. Brentjens?
ScholarIQh-index
Renier J. Brentjens has an h-index of 78 in OpenAlex.
What is the i10-index of Renier J. Brentjens?
ScholarIQi10-index
Renier J. Brentjens has an i10-index of 172 in OpenAlex.
What is the ORCID of Renier J. Brentjens?
ScholarIQorcid
The ORCID for Renier J. Brentjens is on the source record.
What is the OpenAlex record for Renier J. Brentjens?
ScholarIQopenalex
The OpenAlex for Renier J. Brentjens is on the source record.
What are the most-cited papers on Renier J. Brentjens?
ScholarIQmost cited works
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila, Isabelle Rivière, Xiuyan Wang, Shirley Bartido, Jae H. Park, Kevin J. Curran, Stephen S. Chung, Jolanta Stefanski, Oriana Bórquez-Ojeda, Malgorzata Olszewska, Jinrong Qu, Teresa Wasielewska, Qing He, Mitsú J. Fink, Himaly Shinglot, Maher Youssif, Mark Satter, Yongzeng Wang, James Hosey, Hilda Quintanilla, Elizabeth Halton, Yvette Bernal, Diana Bouhassira, Maria E. Arcila, Mithat Gönen, Gail J. Roboz, P. Maslak, Dan Douer, Mark G. Frattini, Sergio Giralt, Michel Sadelain, Renier J. Brentjens
A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab
Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière, Stephen B. Solomon, Valerie W. Rusch, Roisin E. O’Cearbhaill, Amy Zhu, Waseem Cheema, Navin K. Chintala, Elizabeth Halton, John Pineda, Rocío Pérez-Johnston, Kay See Tan, Bobby Daly, Jose A. Araujo Filho, Daniel Ngai, Erin McGee, A. Vincent, Claudia Diamonte, Jennifer L. Sauter, Shanu Modi, Devanjan Sikder, Brigitte Sénéchal, Xiuyan Wang, William D. Travis, Mithat Gönen, Charles M. Rudin, Renier J. Brentjens, David R. Jones, Michel Sadelain
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
Mythili Koneru, Roisin E. O’Cearbhaill, Swati Pendharkar, David R. Spriggs, Renier J. Brentjens